< div class= " field-label " > Dateline City: < /div > < div class= " field-items " > < div class= " field-item odd " > KENILWORTH, N.J. < /div > < /div > < /div > < p > KENILWORTH, N.J. – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today issued the ..."> < div class= " field-label " > Dateline City: < /div > < div class= " field-items " > < div class= " field-item odd " > KENILWORTH, N.J. < /div > < /div > < /div > < p > KENILWORTH, N.J. – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today issued the ..." /> < div class= " field-label " > Dateline City: < /div > < div class= " field-items " > < div class= " field-item odd " > KENILWORTH, N.J. < /div > < /div > < /div > < p > KENILWORTH, N.J. – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today issued the ..." />

Merck Statement on FDA Advisory Committee Meeting for ZINPLAVA ™ (bezlotoxumab), an Investigational Agent for Prevention of Clostridium difficile Infection Recurrence

< div class= " field field-type-text field-field-press-release-city field-fieldpressreleasecity " > < div class= " field-label " > Dateline City: < /div > < div class= " field-items " > < div class= " field-item odd " > KENILWORTH, N.J. < /div > < /div > < /div > < p > KENILWORTH, N.J. – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today issued the following statement after the conclusion of a meeting of the Antimicrobial Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) to discuss ZINPLAVA™ (bezlotoxumab), an investigational agen t for prevention of < i > Clostridium difficile < /i > ( < i > C. difficile < /i > ) infection recurrence. The Advisory Committee agreed, with a vote of 10 to 5 with one abstention, that Merck has provided substantial evidence of the safety and effectiveness of bezlotoxumab for the prevention of < i > C. < /i > < /p > < div class= " field field-type-text field-field-press-release-language field-fieldpressreleaselanguage " > < div class= " field-label " > Language: < /div > < div class= " field-items " > < div class= " field-item odd " > English < /div > < /div > < /div > < p > < a href= " http://www.mercknewsroom.com/news-release/merck-statement-fda-advisory-committee-meeting-zinplava-bezlotoxumab-investigational-ag " target= " _blank " > read more < /a > < /p >
Source: Merck.com - Corporate News - Category: Pharmaceuticals Tags: Corporate News Latest News Source Type: news